1. Why do we need to change the current way in which pathology services are delivered?
The NHS needs to ensure it is able to provide sustainable high quality, resilient and efficient services in the years ahead. Through greater collaboration across South Yorkshire and Bassetlaw (SYB) pathology services, there are opportunities to benefit both patients and staff in a way that could not be achieved by Trusts in isolation. This includes development of common approaches to respond to increasing demand and use of new technologies over the coming years.
2. What are the NHS Improvement (NHSI) Pathology Networks?
NHSI published 29 proposed pathology networks across the NHS in England in September 2017. These grouped pathology services based on regional alignment, and divided services between “hubs” and “spokes”. Within SYB, Sheffield Teaching Hospitals FT (STHFT) was identified as the hub and the other services were identified as spokes.
As a specialist Trust, Sheffield Children’s FT was not originally included in the SYB network, but this was then confirmed in late December. However, this service delivers a number of specialist tests for which it may be more appropriate to network with other specialist children’s services across the country.
3. Do Networks have to implement the NHSI hub and spoke model?
The requirement on Trusts is for Networks to consider the implications of implementing the hub and spoke model and adopt the most appropriate networked model for the geographical area. This scoping work is underway and is overseen by the Pathology Steering Group attended by General Managers and Clinical Directors, and chaired by a Trust Chief Executive.
Reference Groups for blood sciences, microbiology / virology and histopathology have been initiated to provide feedback on the implications of the NHSI model and wider network opportunities across SYB.
4. Don’t we already have a form of hub and spoke model in place across SYB?
There is already a form of hub and spoke model in place across SYB, with services referring a number of specialist tests to STHFT. However the NHSI model assumes a much higher level of work undertaken by the hub on behalf of Trusts and primary care.
5. When will a decision be taken on whether to implement the NHSI Hub and Spoke model?
No formal decisions have yet been taken on implementing all, or part of the NHSI model, but all Trusts have confirmed their support, subject to agreeing the best model. This will be informed by a full option appraisal and the development of a business case over the coming months. This will be overseen by the Pathology Steering Group with engagement of Reference Groups for blood sciences, microbiology/ virology and histopathology.
There are a number of key implications in relation to increased networking between services, which will need to be scoped as part of the business case. This includes the need to ensure continued accreditation with ISO requirements and maintained clinical quality / patient safety, implementation of common IT systems and robust logistics.
A Memorandum of Understanding has been developed which sets out Trust commitment to work together in a (as yet to be agreed) networked model.
6. How is any investment that is required (e.g. IT) going to be found?
Investment requirements will include IT, logistics, and potentially estate, and will be incorporated into the business case over the coming months.
Trusts will need to confirm through the business case that the benefits justify any investment requirements. There may also be some national funding that becomes available to support networks.
7. Does STHFT have the capacity as hub to take on extra tests?
The capacity at STHFT to take on additional tests is being scoped, as are the associated requirements including IT and logistics.
8. What are the timescales for implementation of any new model?
The option appraisal to consider the NHSI model and the development of a business case will take a number of months to complete as we ensure that any decisions are based upon sound understanding of implications of any change. These will include key risks, issues or investment requirements of the NHSI model compared to continuing with existing services.
Any implementation of service changes that are agreed will be phased to mitigate disruption to service delivery and staff. Some changes may take years to implement owing to requirements such as IT and alignment with contract end points.
9. Will there be any job losses?
Our workforce is the backbone of pathology services and we are very keen to ensure this process does not create unnecessary anxiety for colleagues about job losses.
At this stage the focus is simply to scope the implications of implementing the NHSI model across SYB, which would be likely to take some time to implement in full. In the long term any service changes that do take place will be managed to mitigate negative impact on staff, and by working together on a longer term plan there will be an opportunity to realign services as posts become vacant.
10. Are medical consultants included within scope the NHSI model?
Medical consultant roles are a key part of pathology services and so are included within the scope of the SYB review but have not been included in the NHSI assumptions.
11. How will staff be kept updated on the SYB Network?
A full communications and engagement plan will be launched in March 2018 which includes regular updates and web resources which colleagues can access to be kept abreast of developments, and to understand how to be involved in the process.
If you have any queries please contact your service manager, and we will use your queries to support the development of this FAQ.